The developers of a new groundbreaking prostate cancer test are claiming a major advancement in the field. The ClarityDX prostate test, created by Nanostics, an Edmonton-based company, has been supported by the Alberta Cancer Foundation and is now available in the province. According to Dr. John Lewis, CEO of Nanostics and oncology professor at the University of Alberta, the test is a non-invasive blood test that significantly improves accuracy in determining whether a man should undergo a biopsy for prostate cancer. This test will revolutionize the way men diagnose and decide on treatment for prostate cancer.
Typically, men are advised to start PSA screening at age 50. However, Lewis claims that the ClarityDX test is three times more accurate than current screening methods in detecting clinically significant prostate cancer. The company suggests that the test could potentially reduce unnecessary prostate biopsies by up to 35%, sparing men from invasive and potentially dangerous procedures.
Nanostics claims that the ClarityDX test took 12 years to develop, with support from the Alberta Cancer Foundation. Christy Holtby, VP of Philanthropy at the foundation, emphasizes the importance of early diagnosis in cancer journeys. The test currently costs $300 per patient, but stakeholders are working to introduce it to the public healthcare system in Alberta through the Alberta Health Service’s evidence decision support program. Kerry Williamson, spokesperson for Alberta Health Services, acknowledges the potential and benefits of the ClarityDX Prostate test and looks forward to further review and analysis.
“So if we can do that earlier, more accurately and less invasively, that’s going to be game-changing.” – Christy Holtby, Alberta Cancer Foundation VP of Philanthropy
© 2023 Global News, a division of Corus Entertainment Inc.
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
